COGNITIVE FUNCTION ASPECTS IN HIV-ASSOCIATED CEREBRAL TOXOPLASMOSIS: A CASE REPORT

Authors

  • Lasta Arshinta Department of Neurology, Neurology Resident, Faculty of Medicine, Udayana University, Prof. Dr. IGNG. Ngoerah General Hospital, Denpasar, Bali, Indonesia.
  • Anak Agung Ayu Putri Laksmidewi Department of Neurology, Faculty of Medicine, Udayana University, Prof. Dr. IGNG. Ngoerah General Hospital, Denpasar, Bali, Indonesia.
  • Ni Wayan Nurlina Ekasari Department of Neurology, Mangusada General Hospital, Badung, Bali, Indonesia.
  • Dian Kusumastuti Anggraeni Putri Department of Neurology, Mangusada General Hospital, Badung, Bali, Indonesia
  • Gede Suputra Department of Neurology, Mangusada General Hospital, Badung, Bali, Indonesia
  • Bagus Ngurah Mahasena Putera Awatara Department of Neurology, Mangusada General Hospital, Badung, Bali, Indonesia

DOI:

https://doi.org/10.21776/ub.mnj.2024.010.02.18

Keywords:

cerebral toxoplasmosis, human-immunodeficiency virus, cognitive function, hiv-associated neurocognitive disorders

Abstract

HIV-associated cerebral toxoplasmosis may lead to cognitive function impairment through accumulation of β-amyloid plaques and Tau protein which cause damage, inflammatory and oxidative processes in the brain. A 40-year-old, Balinese, right-handed female patient, came with chief complaint of three times of seizure before admission. After the seizures stopped, the patient was fully conscious again. Since the last 2 months, the patient seemed more confused and spoke a little slower. The patient also often repeated a story about something and forgot that she had already told it. The patient has a known history of HIV infection in the past 3 months before admission, she had taken anti-retroviral agents but she stopped them by herself since last 1 month. Anti-Toxoplasma IgG antibody showed reactive results and CD-4 of 62 cells/µL. The results of the overall cognitive function examination found mild cognitive impairment with activities that required mild assistance. HIV-associated neurocognitive disorders (HAND) are still a challenge to study, and the importance of improving patient cognitive function to maintain or increase aspects of independence and quality of life is a target in the care of HIV patients, especially patients with HIV-associated cerebral toxoplasmosis infection.

Downloads

Download data is not yet available.

References

Ahmad AF, Ngui R, Muhammad Aidil R, Lim YAL, Rohela M. Current status of parasitic infections among Pangkor Island community in Peninsular Malaysia. Trop Biomed; 2014. 31(4):836-843. Available from: https://pubmed.ncbi.nlm.nih.gov/25776610/

Sanni Hassana D, Hadisaputro S, Sofro MAU. Toxoplasmosis and cerebral toxoplasmosis in HIV/AIDS patients in Kariadi Hospital, Semarang. J Epidemiol Kesehat Komunitas; 2021. 6(1):213-217. DOI: 10.14710/jekk.v6i1.7351

Eka Febianingsih NP, Indriani C, Artama WT. Seroprevalensi toksoplasmosis di Kabupaten Gianyar, Bali. Ber Kedokt Masy; 2017. 33(2):61.

DOI: 10.22146/bkm.11400

Mitra P, Sharman T. HIV Neurocognitive Disorders - StatPearls - NCBI Bookshelf. StatPearls [Internet] Treasure Isl StatPearls Publ. Published Online; 2021. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK555954/

Bharti AR, McCutchan A, Deutsch R, et al. Latent toxoplasma infection and higher toxoplasma gondii immunoglobulin G levels are associated with worse neurocognitive functioning in HIV-infected adults. Clin Infect Dis; 2016. 63(12):1655-1660.

DOI: 10.1093/cid/ciw655

Yang HY, Chien WC, Chung CH, et al. Risk of dementia in patients with toxoplasmosis: A nationwide, population-based cohort study in Taiwan. Parasites and Vectors; 2021. 14(1):1-11. DOI: 10.1186/s13071-021-04928-7

Ortiz‐Guerrero G, Gonzalez‐Reyes RE, De‐la‐torre A, Medina‐Rincón G, Nava‐Mesa MO. Pathophysiological mechanisms of cognitive impairment and neurodegeneration by Toxoplasma gondii infection. Brain Sci; 2020. 10(6):1-19.

DOI: 10.3390/brainsci10060369

Wang ZD, Wang SC, Liu HH, et al. Prevalence and burden of toxoplasma gondii infection in HIV-infected people: A systematic review and meta-analysis. Lancet HIV; 2017. 4(4):e177-e188. DOI: 10.1016/S2352-3018(17)30005-X

Dian S, Ganiem AR, Ekawardhani S. Cerebral toxoplasmosis in HIV-infected patients: A review. Pathog Glob Health; 2023. 117(1):14-23.

DOI: 10.1080/20477724.2022.2083977

de Almondes KM, Lima NC. Cerebral toxoplasmosis and alcohol abuse in AIDS: Dementia with multiple etiologies. Dement e Neuropsychol; 2020. 14(4):422-429. DOI: 10.1590/1980-57642020dn14-040014

Ene L, Marcotte TD, Umlauf A, et al. Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. J Neuroimmunol; 2016. 299:1-7.

DOI: 10.1016/j.jneuroim.2016.08.003

Gunawijaya D, Kusumastuti D, Putra W, Ekasari N. Cognitive impairment in cerebral toxoplasmosis with pre-HAART HIV infection: A case report. Intisari Sains Medis; 2019. 10(2):481-484.

DOI: 10.15562/ism.v10i2.177

Munir B, Rianawati SB, Rosyid H Al. The comparison of cognitive function disorder before and after early therapy for cerebral toxoplasmosis in HIV/AIDS patients. HIV AIDS Rev; 2020. 9(1):30-33.

DOI: 10.5114/hivar.2020.93159

Chalermchai T, Valcour V, Sithinamsuwan P, et al. Trail making test a improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND. J Neurovirol; 2013. 19(2):137-143. DOI: 10.1007/s13365-013-0151-4

F A. HIV-1 Associated Toxoplasmosis - StatPearls - NCBI Bookshelf. StatPearls. Published online; 2022. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK441877/

Downloads

Published

2024-06-05

How to Cite

Lasta Arshinta, Anak Agung Ayu Putri Laksmidewi, Ni Wayan Nurlina Ekasari, Dian Kusumastuti Anggraeni Putri, Gede Suputra, & Bagus Ngurah Mahasena Putera Awatara. (2024). COGNITIVE FUNCTION ASPECTS IN HIV-ASSOCIATED CEREBRAL TOXOPLASMOSIS: A CASE REPORT. MNJ (Malang Neurology Journal), 10(2), 180–183. https://doi.org/10.21776/ub.mnj.2024.010.02.18

Issue

Section

Case Report